These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12154777)

  • 1. Report of the 11th EASD Islet Group meeting. Glasgow, UK, 13-15 September 2001.
    Furman BL; Flatt PR
    Diabetologia; 2002 Jun; 45(6):R26-9. PubMed ID: 12154777
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from the post-EASD symposium of the EASD-Islet Study Group, "Pancreatic Islet Research-Towards the Year 2000", held 16-18 September 1995, Sigtuna, Sweden.
    Diabetologia; 1996 Mar; 39(3):suppl 21-4. PubMed ID: 8721790
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment.
    Mahler RJ; Adler ML
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1165-71. PubMed ID: 10199747
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance and beta-cell function--a clinical perspective.
    Matthews DR
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S28-33. PubMed ID: 11685826
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolomics applied to the pancreatic islet.
    Gooding JR; Jensen MV; Newgard CB
    Arch Biochem Biophys; 2016 Jan; 589():120-30. PubMed ID: 26116790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitizers.
    Das S
    J Assoc Physicians India; 1997; Suppl 1():32-6. PubMed ID: 11235632
    [No Abstract]   [Full Text] [Related]  

  • 7. Future trends in diabetes management.
    George CM
    Nephrol Nurs J; 2009; 36(5):477-83. PubMed ID: 19856809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.
    Pratley R
    Endocrinol Metab Clin North Am; 2006 Dec; 35 Suppl 1():6-11; discussion 17-19. PubMed ID: 17424674
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal Models of Islet Dysfunction. Proceedings of the 8th Servier-IGIS Symposium, St Jean Cap Ferrat, France, 8-11 March 2007.
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():1-209. PubMed ID: 18376451
    [No Abstract]   [Full Text] [Related]  

  • 10. Of mighty mice and diabetic men: animal models of islet dysfunction.
    Efendic S; Boitard C; Ferrannini E; Henquin JC; Steiner DF; Cerasi E
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():1-4. PubMed ID: 17919172
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm.
    Green J; Feinglos M
    Int J Clin Pract Suppl; 2007 Aug; (154):3-11. PubMed ID: 17593272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating type 2 diabetes--today's targets, tomorrow's goals.
    Alberti KG
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S3-10. PubMed ID: 11685827
    [No Abstract]   [Full Text] [Related]  

  • 13. Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
    Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JA
    Diabetes Care; 2008 Feb; 31 Suppl 2():S161-4. PubMed ID: 18227479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfecting insulin. The challenges of making this lifesaver work like a pancreas.
    Tanenberg RJ
    Diabetes Forecast; 2012 Jul; 65(7):38-9. PubMed ID: 22827013
    [No Abstract]   [Full Text] [Related]  

  • 15. The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy.
    Greco AV; Caputo S; Bertoli A; Ghirlanda G
    Horm Metab Res; 1992 Jun; 24(6):280-3. PubMed ID: 1634193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta cells in Type II diabetes: culprit or victim?].
    Scheen AJ; Paquot N; Lefebvre PJ
    Journ Annu Diabetol Hotel Dieu; 1991; ():153-69. PubMed ID: 1886327
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.
    Marchetti P; Del Guerra S; Marselli L; Lupi R; Masini M; Pollera M; Bugliani M; Boggi U; Vistoli F; Mosca F; Del Prato S
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5535-41. PubMed ID: 15531508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapies for type 1 diabetes mellitus].
    Maruyama T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():190-5. PubMed ID: 12386992
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic islet regeneration by ephedrine in mice with streptozotocin-induced diabetes.
    Xiu LM; Miura AB; Yamamoto K; Kobayashi T; Song QH; Kitamura H; Cyong JC
    Am J Chin Med; 2001; 29(3-4):493-500. PubMed ID: 11789592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.